Assessment of Response to Radiotherapy for Prostate Cancer: Value of Diffusion-Weighted MRI at 3 T
Authors:
- 1 June 2010
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 194 (6) , W477-W482
Abstract
OBJECTIVE. The objective of our study was to investigate the changes of apparent diffusion coefficient (ADC) values in prostate cancers before and after radiotherapy at 3 T using a phased-array coil.MATERIALS AND METHODS. Forty-nine patients with biopsy-proven prostate cancer who received radiotherapy underwent diffusion-weighted imaging (DWI) at 3 T and were included in the study. Biopsies in all patients were performed before the initial MRI examination (range, 15–35 days before MRI; mean, 23.4 days). All 49 patients underwent DWI (b values = 0 and 1,000 s/mm2) before and 1–5 months after the completion of radiotherapy. The changes in ADC values were measured for cancers and benign tissues before and after therapy. Additionally, the changes in serum prostate-specific antigen (PSA) levels were evaluated before and after therapy.RESULTS. A total of 57 cancers (peripheral zone, n = 45; transition zone, n = 12) were found in 46 patients. For the tumors, the mean ADC value after therapy (1.61 × 10–3 mm2/s) w...Keywords
This publication has 23 references indexed in Scilit:
- An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation InteractionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- 13-Year Outcomes Following Treatment for Clinically Localized Prostate Cancer in a Population Based CohortJournal of Urology, 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Treatment decision‐making strategies and influences in patients with localized prostate carcinomaCancer, 2005
- LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCERJournal of Urology, 2005
- Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor responseProceedings of the National Academy of Sciences, 2005
- Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen eraCancer, 2002
- Practical application of biochemical failure definitions: what to do and when to do itInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Usefulness of prostate-specific antigen velocity in screening for prostate cancer.International Journal of Urology, 2002
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991